When Kazuko Shiraishi was severely ill with depression, she stopped being able to see colour – and then to taste or smell. With her senses shutting down, she longed to let go entirely.
With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.
The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.